Ninth Cir­cuit backs dis­trict court, toss­es Nexus Phar­ma ap­peal in com­pound­ing drug suit

3 years ago
Pharma
Law

US gov­ern­ment pledges $2B for new ini­tia­tive on bio­man­u­fac­tur­ing

3 years ago
Pharma
Manufacturing

Crunch time for FDA user fees as reau­tho­riza­tion looks to hitch a ride on short-term spend­ing bill

3 years ago
FDA+

Fed­er­al judge dis­miss­es kick­back claims in No­var­tis whistle­blow­er case — again

3 years ago
Pharma
Law

Re­tir­ing Re­pub­li­can sen­a­tor lam­basts Biden ap­pointees' re­sponse to mon­key­pox out­break

3 years ago
FDA+
Law

Is Lil­ly plan­ning two brands for tirzepatide? CFO dis­cuss­es di­a­betes and obe­si­ty pos­si­bil­i­ties

3 years ago
Pharma
Marketing

Genen­tech-part­nered Novome lands $43.5M to push gas­troin­testi­nal drug through mid-stage study

3 years ago
Financing

Cardiff drops its prostate can­cer pro­gram, send­ing shares in­to a tail­spin

3 years ago
R&D

Can a spe­cial chew­ing gum slick away Covid-19 from sali­va? Penn re­searchers start clin­i­cal tri­al to find out

3 years ago
Discovery
Coronavirus

With pos­i­tive PhII NASH da­ta in tow, Akero opens $175M pub­lic of­fer­ing

3 years ago
Financing

Still leery about an­i­mal deaths, FDA lifts a full hold on Friedre­ich’s atax­ia drug — but there’s a big ...

3 years ago
FDA+

Take­da’s man­u­fac­tur­ing site in Bel­gium gets a €300M boost for plas­ma ther­a­py pro­duc­tion

3 years ago
Financing
Manufacturing

A $105M SPAC deal? Re­al­ly? A biotech with deep Chi­na roots is mak­ing a now-rare flip on­to Nas­daq

3 years ago
Financing

'Not To­day, Flu': Sanofi en­lists Se­in­feld star Ja­son Alexan­der to boost flu vac­ci­na­tions this fall

3 years ago
Pharma
Marketing

Gov­ern­ment-paid ex­perts help­ing in­dus­try at the ta­ble with FDA? Agency spells out guardrails

3 years ago
FDA+

Backed by five phar­ma gi­ants and a crew of Penn su­per­stars, a start­up us­es mR­NA to cre­ate in vi­vo CAR-T — with a ...

3 years ago
Financing
Startups

CSL takes the wraps off a big new R&D cen­ter as it eyes vac­cines, cell and gene ther­a­pies

3 years ago
R&D
Pharma

‘Dif­fi­cult to go pub­lic with’: Spar­ingVi­sion turns to ex­ist­ing back­ers to fund its first two oc­u­lar gene ther­a­py ...

3 years ago
Financing
Startups

Ab­b­Vie un­veils 'See Your­self' Botox cam­paign, days af­ter new ri­val ap­proved

3 years ago
Pharma
Marketing

Ab­b­Vie spon­sors on­line atopic der­mati­tis doc­u­men­tary de­but, re­veals new lifestyle da­ta

3 years ago
Pharma
Marketing

As­traZeneca wins fed­er­al class-ac­tion suit, judge dis­miss­es share­hold­er­s' mis­lead­ing claims

3 years ago
Pharma
Law

New gener­ics save pa­tients bil­lions per year, ac­cord­ing to FDA re­port

3 years ago
Pharma
FDA+

Form 483 un­masks man­u­fac­tur­ing is­sues at Alvotech be­fore its CRL, and one for Au­robindo too

3 years ago
Pharma
FDA+

Mar­ket­ingRx roundup: Am­gen ‘sum­mer of sci­ence’ sun­sets In­sta­gram run; Pfiz­er vaults in­to top 10 of con­sumer loy­al ...

3 years ago
Pharma
Marketing
First page Previous page 462463464465466467468 Next page Last page
A service from the Financial Times